The Meda Pharmaceutical product portfolio is focused primarily on respiratory, allergy, central nervous system, gastroenterology, musculoskeletal, rheumatology, erectile dysfunction, and women's health products.

The product information presented here is intended for use in the United States only. Other countries may have different regulatory requirements and review practices that may require referencing different information.

To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc.
at 1-800-526-3840 or FDA at 1-800-FDA-1088 or

Product Name
(active ingredient)
Prescribing InformationProduct Web Site
AerospanTM Inhalation Aerosol
Aerospan Prescribing Information

Aerospan Patient Information
Anadrol-50® Tablet, For Oral Administration CIII, 50 mg
Anadrol-50 Tablet Prescribing Information 
Astelin® Nasal Spray, 137 mcg
(azelastine hydrochloride)
Astelin Prescribing Information
Astepro® Nasal Spray, 0.15%
(azelastine hydrochloride)
Astepro Prescribing Information 
AVC® Cream
AVC Cream Prescribing Information 
BiferaRx® Tablet
(iron supplement)
BiferaRx Tablet Prescribing Information 
Butisol Sodium® Tablets, 30 mg and 50 mg
and Oral Solution, 30 mg/5 mL
(butabarbital sodium)
Butisol Sodium Tablet and Oral Solution Prescribing Information  
Cesamet® Capsules , For Oral Administration CII, 1 mg
Cesamet Prescribing Information – 50 Count Bottle
Colyte® Powder for Solution with Flavor Packets
(peg-3350 & electrolytes)
Colyte 4 Liter Prescribing Information  
Cortifoam® 10% Rectal Foam
(hydrocortisone acetate rectal aerosol)
Cortifoam Foam Prescribing Information 
Demadex® Tablets 5 mg, 10 mg, 20 mg, and 100 mg
Demadex Tablet Prescribing Information 
Depen® (Penicillamine Tablets, USP) Titratable Tablets
Depen Tablet Prescribing Information  
Dipentum® Capsules
(olsalazine sodium)
Dipentum Capsule Prescribing Information  
Dymista® (azelastine hydrochloride and fluticasone propionate) Nasal Spray 137 mcg / 50 mcg Per Spray Dymista Prescribing
Edluar® Sublingual Tablets, For Oral Use C-IV, 5 mg and 10 mg
(zolpidem tartrate)
Edluar Sublingual Tablet Prescribing Information
Elestrin® Gel
(estradiol gel)
Elestrin Prescribing
Epifoam® Topical Aerosol
(hydrocortisone acetate 1% and pramoxine hydrochloride 1%)
Epifoam Prescribing Information  
Felbatol® Tablets, 400 mg and 600 mg,
and Oral Suspension, 600 mg/5 mL
Felbatol Tablet and Oral Suspension Prescribing Information
Gastrocrom® Oral Concentrate
(cromolyn sodium, USP)
Gastrocom Prescribing Information  
Gesticare® DHA Tablets
(Prenatal Multi-vitamin/Mineral Tablets with DHA and Choline)
Gesticare DHA Prescribing Information  
Levbid® Extended-Release Tablet, 0.375mg
(hyoscyamine sulfate)
Levbid Tablet Prescribing Information  
Levsin®/SL Tablets
(hyoscyamine sulfate tablets USP)
Levsin/SL Tablet Prescribing Information  
Levsin® Injection
(hyoscyamine sulfate injection USP)
Levsin Injection Prescribing Information  
Levsin® Tablets
(hyoscyamine sulfate tablets USP)
Levsin Tablet Prescribing Information  
Lufyllin® Tablets, 200 mg and 400 mg
Lufyllin Tablet Prescribing Information  
MUSE® Urethral Suppository
MUSE Urethral Suppository Prescribing Information

MUSE Patient Information
Natelle®One Capsules
(Rx Prenatal Vitamin & Plant-Based DHA. Now with 28 mg Iron)
Natelle One Prescribing Information  
NuLev®Chewable Melt Tablets
(hyoscyamine sulfate USP)
NuLev Tablet Prescribing Information  
Optivar® 0.05% Ophthalmic Solution
(azelastine hydrochloride)
Optivar Prescribing Information
PreferaOB ONE® Softgel
PreferaOB ONE Prescribing Information
PreferaOB Tablet + DHA® Softgel
PreferaOB + DHA Prescribing Information
PreferaOB® Tablet
PreferaOB Prescribing Information
Proctofoam® (Non-Steriod) Hemorrhoidal Foam
(pramoxine hydrochloride 1%)
Proctofoam NS Drug Facts  
Proctofoam® HC Aerosol Foam
(hydrocortisone acetate 1% and pramoxine hydrochloride 1%)
Proctofoam HC Prescribing Information  
Rowasa® Rectal Suspension
Rowasa Prescribing Information  
sfRowasaTM Rectal Suspension, Sulfite-Free Formulation
sfRowasa Prescribing Information  
Soma® Tablets, For Oral Use C-IV, 250 mg and 350 mg
Soma Tablet Prescribing Information
Urelle® Tablets
(Urinary Antiseptic)
Urelle Prescribing Information  

You will need Adobe® Reader.

To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc.
at 1-800-526-3840 or FDA at 1-800-FDA-1088 or